235 related articles for article (PubMed ID: 17803032)
1. LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.
Dupré N; Rivière JB; Myers RH; Provencher P; Pourcher E; Emond F; Rouleau GA
Can J Neurol Sci; 2007 Aug; 34(3):333-5. PubMed ID: 17803032
[TBL] [Abstract][Full Text] [Related]
2. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
3. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
[TBL] [Abstract][Full Text] [Related]
6. Is the G2019S LRRK2 mutation common in all southern European populations?
Papapetropoulos S; Adi N; Shehadeh L; Bishopric N; Singer C; Argyriou AA; Chroni E
J Clin Neurosci; 2008 Sep; 15(9):1027-30. PubMed ID: 18617409
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease.
Patra B; Parsian AJ; Racette BA; Zhao JH; Perlmutter JS; Parsian A
Parkinsonism Relat Disord; 2009 Mar; 15(3):175-80. PubMed ID: 18752982
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 screening in a Canadian Parkinson's disease cohort.
Grimes DA; Racacho L; Han F; Panisset M; Bulman DE
Can J Neurol Sci; 2007 Aug; 34(3):336-8. PubMed ID: 17803033
[TBL] [Abstract][Full Text] [Related]
9. The age at motor symptoms onset in LRRK2-associated Parkinson's disease is affected by a variation in the MAPT locus: a possible interaction.
Gan-Or Z; Bar-Shira A; Mirelman A; Gurevich T; Giladi N; Orr-Urtreger A
J Mol Neurosci; 2012 Mar; 46(3):541-4. PubMed ID: 21898123
[TBL] [Abstract][Full Text] [Related]
10. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Ross OA; Soto-Ortolaza AI; Heckman MG; Aasly JO; Abahuni N; Annesi G; Bacon JA; Bardien S; Bozi M; Brice A; Brighina L; Van Broeckhoven C; Carr J; Chartier-Harlin MC; Dardiotis E; Dickson DW; Diehl NN; Elbaz A; Ferrarese C; Ferraris A; Fiske B; Gibson JM; Gibson R; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lesage S; Lin CH; Lynch T; Maraganore DM; Mellick GD; Mutez E; Nilsson C; Opala G; Park SS; Puschmann A; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Theuns J; Tomiyama H; Uitti RJ; Valente EM; van de Loo S; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Farrer MJ;
Lancet Neurol; 2011 Oct; 10(10):898-908. PubMed ID: 21885347
[TBL] [Abstract][Full Text] [Related]
11. The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease.
Cho JW; Kim SY; Park SS; Kim HJ; Ahn TB; Kim JM; Jeon BS
Can J Neurol Sci; 2007 Feb; 34(1):53-5. PubMed ID: 17352347
[TBL] [Abstract][Full Text] [Related]
12. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
[TBL] [Abstract][Full Text] [Related]
14. Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.
Bar-Shira A; Hutter CM; Giladi N; Zabetian CP; Orr-Urtreger A
Neurogenetics; 2009 Oct; 10(4):355-8. PubMed ID: 19283415
[TBL] [Abstract][Full Text] [Related]
15. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
[TBL] [Abstract][Full Text] [Related]
16. A study of LRRK2 mutations and Parkinson's disease in Brazil.
Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
[TBL] [Abstract][Full Text] [Related]
17. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.
Thaler A; Ash E; Gan-Or Z; Orr-Urtreger A; Giladi N
J Neural Transm (Vienna); 2009 Nov; 116(11):1473-82. PubMed ID: 19756366
[TBL] [Abstract][Full Text] [Related]
18. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease.
Deng H; Le W; Huang M; Xie W; Pan T; Jankovic J
Neurosci Lett; 2007 May; 419(2):104-7. PubMed ID: 17482357
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.
Bardien S; Marsberg A; Keyser R; Lombard D; Lesage S; Brice A; Carr J
J Neural Transm (Vienna); 2010 Jul; 117(7):847-53. PubMed ID: 20544233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
